Abstract:Photodynamic therapy (PDT), characterized by high treatment efficiency, absence of drug resistance, minimal trauma, and few side effects, has gradually emerged as a novel and alternative clinical approach compared to traditional surgical resection, chemotherapy and radiation. Whereas, considering the limited diffusion distance and short lifespan of reactive oxygen species (ROS), as well as the hypoxic tumor microenvironment, it is crucial to design photosensitizers (PSs) with suborganelle specific targeting ability and low-oxygen dependence for accurate and highly efficient photodynamic therapy. In this study, we have meticulously designed three PSs, namely CIH, CIBr, and CIPh, based on molecular engineering. Theoretical calculation demonstrate that the three compounds possess good molecular planarity with calculated S1-T1 energy gaps (ΔES1-T1) of 1.04 eV for CIH, 0.92 eV for CIBr, and 0.84 eV for CIPh respectively. Notably, CIPh showcases remarkable dual subcellular targeting capability towards lipid droplets (LDs) and mitochondria owing to the synergistic effect of lipophilicity derived from coumarin's inherent properties combined with electropositivity conferred by indole salt cations. Furthermore, CIPh demonstrates exclusive release of singlet oxygen (1O2)and highly efficient superoxide anion free radicals(O2⦁-) upon light irradiation supported by its smallest S1-T1 energy gap (ΔES1-T1 = 0.84 eV). This leads to compromised integrity of LDs along with mitochondrial membrane potential, resulting in profound apoptosis induction in HepG2 cells. This successful example of molecular engineering guided by density functional theory (DFT) provides valuable experience for the development of more effective PSs with superior dual targeting specificity. It also provides a new idea for the development of advanced PSs with efficient and accurate ROS generation ability towards fluorescence imaging-guided hypoxic tumor therapy.

Near-Infrared BODIPY Photosensitizer for Modulating Mitochondrial Fusion Proteins and Inhibiting Choroidal Neovascularization

Potent BODIPY-based photosensitisers for selective mitochondrial dysfunction and effective photodynamic therapy

Mitochondria-targeting BODIPY-loaded Micelles As Novel Class of Photosensitizer for Photodynamic Therapy

A Near-Infrared Triggered Nanophotosensitizer Inducing Domino Effect on Mitochondrial Reactive Oxygen Species Burst for Cancer Therapy.

Optimizing Mitochondrial-Targeting Groups of Positively-Charged BODIPY Nanoparticles for Enhanced Photodynamic Therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in Vitro and in Vivo Evaluation for Photodynamic Therapy

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

A protein-conjugated photosensitizer with mitochondrial targeting for enhanced photodynamic therapy

A Mitochondria‐Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR‐II Fluorescence/Photoacoustic Imaging‐Guided Phototherapy

Boosting the Photodynamic Therapy Efficiency with a Mitochondria-Targeted Nanophotosensitizer

Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis-Ferroptosis

Acceptor Substitution Engineering of BODIPY-based Organic Photosensitizers with Aggregation-Induced Emission for Organelle Localization and Photodynamic Anticancer Therapy

Cationic BODIPY Photosensitizers for Mitochondrion-Targeted Fluorescence Cell-Imaging and Photodynamic Therapy

Molecular engineering to elevate reactive oxygen species generation for synergetic damage on lipid droplets and mitochondria

Red-to-near-infrared self-reporting photosensitizers with high photostability for photodynamic therapy

Auto-Deactivation of BODIPY-Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia.

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Benzophenone core based AIE-active Photosensitizers for mitochondria-targeted photodynamic therapy

A NIR molecular rotor photosensitizer for efficient PDT and synchronous mitochondrial viscosity imaging

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy